Effects of serum uric acid on blood-pressure lowering treatment

Abstract

If hyperuricemia is an independent risk factor in blood-pressure control, urate-lowering therapy should be used to reduce cardiovascular risk. It may also act as a prognostic marker of other abnormalities. This review presents current evidence on the relationship between hyperuricemia and hypertension.

Keywords:

• Serum uric acid
• gout
• blood hypertension
• urate lowering therapy

Transparency

Declaration of funding

This review was funded by Fondazione Menarini.

Declaration of financial/other relationships

G.G. has disclosed that he has belonged to speaker’s bureaus from Menarini, Merck and AstraZeneca.

CMRO peer reviewers on this manuscript have received an honorarium from CMRO for their review work, but have no relevant financial or other relationships to disclose.

Acknowledgements

Editorial assistance for this supplement was provided by Content Ed Net funded by Fondazione Menarini.